Evidence map›Paper›PMID 41814203›Full record

ArticleBMC infectious diseases2026

Systemic inflammatory response syndrome in pediatric urinary tract infections associated with urolithiasis: a retrospective study of risk factors, pathogens, and antimicrobial resistance at two tertiary hospitals.

Honggang Fang, Rongyang Zeng, Yihang Yu, Xing Liu, Yi Hua, Shengde Wu, Tao Lin, Dawei He, Jinpu Peng, Guanghui Wei and 1 more

Abstract read
In one paragraph

Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Honggang FangDepartment of Urology, Children's Hospital of Chongqing Medical University, Chongqing, China.
Rongyang ZengDepartment of Pediatric Surgery, Guizhou Provincial People's Hospital, Guiyang, China.
Yihang YuDepartment of Urology, Children's Hospital of Chongqing Medical University, Chongqing, China.
Xing LiuDepartment of Urology, Children's Hospital of Chongqing Medical University, Chongqing, China.
Yi HuaDepartment of Urology, Children's Hospital of Chongqing Medical University, Chongqing, China.
Shengde WuDepartment of Urology, Children's Hospital of Chongqing Medical University, Chongqing, China.
Tao LinDepartment of Urology, Children's Hospital of Chongqing Medical University, Chongqing, China.
Dawei HeDepartment of Urology, Children's Hospital of Chongqing Medical University, Chongqing, China.
Jinpu PengDepartment of Pediatric Surgery, Guizhou Provincial People's Hospital, Guiyang, China.
Guanghui WeiDepartment of Urology, Children's Hospital of Chongqing Medical University, Chongqing, China.
Deying ZhangDepartment of Urology, Children's Hospital of Chongqing Medical University, Chongqing, China. zdy@hospital.cqmu.edu.cn.

Funding

Chongqing key project of technology innovation and application 2024TIAD-KPX0035CQMU Program for Youth Innovation in Future Medicine W0056Joint project of Chongqing Health Commission and Science and Technology Bureau 2025ZDXM038
6 · The paper itself

Abstract

backgroundUrinary tract infections (UTIs) in children with urinary calculi are frequently caused by multidrug-resistant organisms and may rapidly progress to systemic inflammatory response syndrome (SIRS). Early diagnosis is challenging due to nonspecific symptoms, especially in younger children. This study aims to identify the risk factors for SIRS and characterize pathogen distribution and antimicrobial resistance patterns in pediatric stone-related UTIs.

methodsWe retrospectively analyzed 198 pediatric patients with culture-positive urinary calculi treated at two tertiary hospitals from January 2017 to December 2024. Bacterial identification and antimicrobial susceptibility profiling were performed using the VITEK 2 automated system (bioMérieux, France) in accordance with Clinical and Laboratory Standards Institute (CLSI) guidelines. Patients were categorized into SIRS and non-SIRS groups according to clinical criteria, and logistic regression was performed to identify risk factors for SIRS.

resultsThe median age was 66 months, and 61.11% were male. The majority of cases involved multiple stones (61.62%) and small stones (93.94%); 14.67% were lower urinary tract stones and 22.22% had urinary tract malformations. Multivariable analysis identified three factors associated with SIRS: recurrent UTIs (OR = 4.95, 95% CI: 2.20–11.13), urinary tract malformations (OR = 2.78, 95% CI: 1.21–6.42), and elevated SIRI (OR = 2.33, 95% CI: 1.41–3.85). The predominant pathogens were Escherichia coli (23.23%), Enterococcus faecium (14.14%), Enterococcus faecalis (14.14%), and Klebsiella pneumoniae (9.60%). Gram-negative bacteria accounted for 61.11% of isolates with non-Escherichia coli strains comprising 76.77%. The most common bacteria were Escherichia coli in girls (32.47%), compared with Enterococcus faecalis in boys (20.66%). Over 70% of Escherichia coli isolates produced ESBLs and 67.39% of isolates were multidrug-resistant; resistance to multiple cephalosporins exceeded 67%, while susceptibility to piperacillin/tazobactam, meropenem, and imipenem was fully preserved.

conclusionRecurrent UTIs, urinary tract malformations, and elevated SIRI values enable early risk stratification for SIRS, while the distinct and resistant pathogen profile mandates a shift from conventional empiric therapy to precision management. CLINICAL TRIAL NUMBER: Not applicable.

Indexed as

Systemic Inflammatory Response SyndromeUrinary Tract InfectionsUrolithiasisAnti-Bacterial AgentsBacteriaChildChild, PreschoolDrug Resistance, BacterialFemaleGram-Negative BacteriaHumansInfantMaleMicrobial Sensitivity TestsRetrospective StudiesRisk FactorsAnti-Bacterial AgentsAntimicrobial ResistanceDiagnostic MarkersPediatric UrolithiasisSystemic Inflammatory Response SyndromeUrinary tract infection

Identifiers

PMID41814203
PMCPMC13094202

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.